BlackRock Advisors’s Medicines Co MDCO Stock Holding History

BlackRock Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.26M	Buy	37,079 +1,601	+5%	+$56.8K	﹤0.01%	1739
2016 Q3	$1.34M	Buy	35,478 +3,077	+9%	+$116K	﹤0.01%	1666
2016 Q2	$1.09M	Buy	32,401 +1,131	+4%	+$39.9K	﹤0.01%	1725
2016 Q1	$993K	Buy	31,270 +2,713	+10%	+$88.6K	﹤0.01%	1741
2015 Q4	$1.07M	Sell	28,557 -13,129	-31%	-$496K	﹤0.01%	1679
2015 Q3	$1.58M	Sell	41,686 -1,968	-5%	-$69.1K	﹤0.01%	1437
2015 Q2	$1.25M	Buy	43,654 +2,156	+5%	+$60.1K	﹤0.01%	1518
2015 Q1	$1.16M	Buy	41,498 +6,086	+17%	+$171K	﹤0.01%	1474
2014 Q4	$980K	Sell	35,412 -1,807	-5%	-$44.8K	﹤0.01%	1513
2014 Q3	$831K	Sell	37,219 -698	-2%	-$17.7K	﹤0.01%	1558
2014 Q2	$1.1M	Sell	37,917 -223,165	-85%	-$5.96M	﹤0.01%	1428
2014 Q1	$7.42M	Sell	261,082 -234,813	-47%	-$7.77M	0.01%	882
2013 Q4	$19.2M	Sell	495,895 -95,221	-16%	-$3.4M	0.02%	567
2013 Q3	$19.8M	Sell	591,116 -207,049	-26%	-$6.6M	0.02%	564
2013 Q2	$24.6M	Buy	+798,165	New	+$26.7M	0.03%	475

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BlackRock Advisors's MDCO Position: Q4 2016 in Review

BlackRock Advisors increased its Medicines Co (MDCO) stake by 4.5% in Q4 2016, buying an estimated $56.8K and bringing the position to 37,079 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

BlackRock Advisors first reported a position in MDCO in Q2 2013 and has held it in 15 quarters since. The position peaked at $24.6M in Q2 2013. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

BlackRock Advisors held 37,079 shares of Medicines Co worth $1.26M as of Q4 2016.
BlackRock Advisors bought 1,601 Medicines Co shares in Q4 2016, an estimated $56.8K.
Medicines Co made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1739 holding.
BlackRock Advisors first reported a position in Medicines Co in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Medicines Co position peaked at $24.6M in Q2 2013.
195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.